Cognivia signal™
Real-time behavioral risk intelligence for clinical trials
Cognivia Signal helps clinical teams reduce and mitigate two critical behavioral risks :
- Participant drop-out,
- Placebo response variability.
Powered by behavioral data and machine learning, the platform delivers real-time dashboards that support early detection of drop-out risk, real-time monitoring of placebo response drivers for patient behavior-informed trial decisions.
Placebell©™
Covariate adjustment to reduce placebo bias in clinical trials.
Placebell is Cognivia’s covariate adjustment approach designed to account for behavioral and contextual factors influencing placebo response.
By integrating behavioral data into statistical models, Placebell helps reduce placebo-related variability—supporting cleaner efficacy signals, improved data interpretation, and more reliable trial outcomes.
Have confidence in your therapy
Clear efficacy demonstration means more confident strategic compound decisions—but behavioral variability complicates decision-making at every level, from study conduct to data analysis.
Drop-out, treatment non-adherence and placebo response introduce noise and risk affecting statistical analysis. Monitor behavioral risks in real time, adjust for placebo-related variability statistically, and strengthen trial outcomes with deeper insight into patient behavior.
What pharma & biotech clients are saying
Bridging Innovation and Experience in Clinical Development.
We've experienced firsthand the frustrations that come from losing a promising drug candidate to the inability to prove efficacy in clinical trials.
Because we're not just tech people, we have deep roots in clinical development.
Understand patient differences in your next clinical trial
Increase your trial’s success rates and bring new therapies to patients faster.
Tell us about your clinical trial below, and our team will be in touch.
"*" indicates required fields